SUPN - Supernus Pharmaceuticals Inc. (SUPN) CEO Jack Khattar on Q4 2021 Results - Earnings Call Transcript
Supernus Pharmaceuticals, Inc. (SUPN) Q4 2021 Earnings Conference Call February 28, 2022 04:30 PM ET Company Participants Peter Vozzo - Westwicke-Investor Relations Jack Khattar - Chief Executive Officer Tim Dec - Chief Financial Officer Conference Call Participants David Steinberg - Jefferies David Amsellem - Piper Sandler Jack Padovano - Stifel Presentation Operator Good afternoon, and welcome to Supernus Pharmaceuticals' Preliminary Fourth Quarter and Full Year 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Instructions will follow at that time. As a reminder, this conference call is being recorded. I would now like to turn the call over to Peter Vozzo of Westwicke, Investor Relations representative for Supernus Pharmaceuticals. You may begin. Peter Vozzo Thank you, May. Good afternoon, everyone and thank you for joining us today for Supernus Pharmaceuticals' preliminary fourth quarter and full year 2021
For further details see:
Supernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q4 2021 Results - Earnings Call Transcript